Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Biostar Pharmaceuticals, Inc. | biostarpharma10k123114.htm |
| EX-32.1 - EX-32.1 - Biostar Pharmaceuticals, Inc. | ex32-1.htm |
| EX-31.1 - EX-31.1 - Biostar Pharmaceuticals, Inc. | ex31-1.htm |
| EX-21 - EX-21 - Biostar Pharmaceuticals, Inc. | ex21.htm |
| EX-32.2 - EX-32.2 - Biostar Pharmaceuticals, Inc. | ex32-2.htm |
| EX-23.2 - EX-23.2 - Biostar Pharmaceuticals, Inc. | ex23-2.htm |
| EX-31.2 - EX-31.2 - Biostar Pharmaceuticals, Inc. | ex31-2.htm |
| EX-23.4 - EX-23.4 - Biostar Pharmaceuticals, Inc. | ex23-4.htm |
| EX-23.1 - EX-23.1 - Biostar Pharmaceuticals, Inc. | ex23-1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Biostar Pharmaceuticals, Inc. | Financial_Report.xls |
Exhibit 23.3
Consent of Independent Registered Public Accounting Firm
To the Board of Directors of
Biostar Pharmaceuticals, Inc.
We hereby consent to the incorporation by reference of our report dated April 15, 2015 with respect of the consolidated financial statement of Biostar Pharmaceuticals, Inc. as of and for the year ended December 31, 2014 into the Annual Report on Form 10-K of Biostar Pharmaceuticals, Inc. for the year ended December 31, 2014, which report will be filed with the U.S. Securities and Exchange Commission on April 15, 2015.
|
/s/ Mazars CPA Limited
|
|
|
Mazars CPA Limited
Certified Public Accountants
|
|
|
Hong Kong
|
|
|
April 15, 2015
|
|